FDG-PET in a myocardial tuberculoma

Age Ageing. 2015 Jan;44(1):173-4. doi: 10.1093/ageing/afu147. Epub 2014 Oct 20.

Authors

Pierre Braquet¹, Gregory Baptista², Diana Alina Ilonca³, François Roubille⁴, Vincent Le Moing⁵, Claude Jeandel⁶

Affiliations

¹ Centre Balmes-Geriatrics, CHU Montpellier, 39, Avenue Charles Flahaut, F-34295 Montpellier Cedex 5, France.
² Department of Geriatrics, CHU Montpellier, Montpellier 34000, France.
³ Department of Nuclear Medicine, CHU Montpellier, Montpellier, France.
⁴ Department of Cardiology and Cardiovascular Medicine, CHU Montpellier, Montpellier, France.
⁵ Department of Infectious Diseases and Tropical Medicine, CHU Montpellier, Montpellier, France.
⁶ Department of Geriatrics, University Hospital of Montpellier, Montpellier, France.

PMID: 25331974
DOI: 10.1093/ageing/afu147

No abstract available

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Antitubercular Agents / therapeutic use
Cardiomyopathies / diagnostic imaging*
Cardiomyopathies / drug therapy
Cardiomyopathies / microbiology
Female
Fluorodeoxyglucose F18*
Heart / diagnostic imaging*
Heart / microbiology
Humans
Positron-Emission Tomography*
Predictive Value of Tests
Radiopharmaceuticals*
Time Factors
Treatment Outcome
Tuberculoma / diagnostic imaging*
Tuberculoma / drug therapy
Tuberculoma / microbiology
Tuberculosis, Cardiovascular / diagnostic imaging*
Tuberculosis, Cardiovascular / drug therapy
Tuberculosis, Cardiovascular / microbiology

Substances

Antitubercular Agents
Radiopharmaceuticals
Fluorodeoxyglucose F18